ANXA5 and systemic lupus erythematosus: ANXA5 also has other properties with direct relevance for SLE in addition to protecting dying cells and inhibiting effects of aPL, namely inhibition of OxLDL pro‐inflammatory properties and instead promoting development of Tregs [118].